Statistics for MiR-16 mediates trastuzumab and lapatinib response in ErbB-2-positive breast and gastric cancer via its novel targets CCNJ. and FUBP1
Total visits
| views | |
|---|---|
| MiR-16 mediates trastuzumab and lapatinib response in ErbB-2-positive breast and gastric cancer via its novel targets CCNJ. and FUBP1 | 62 |
Total visits per month
| views | |
|---|---|
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
File Visits
| views | |
|---|---|
| MiR-16 mediates trastuzumab and lapatinib response in ErbB-2-positive breast and gastric cancer via its novel targets CCNJ and FUBP1.pdf | 18 |
Top country views
| views | |
|---|---|
| United States | 38 |
| Chile | 14 |
| Jordan | 1 |
| Mexico | 1 |
| Sweden | 1 |
Top city views
| views | |
|---|---|
| Miami | 36 |
| Santiago | 13 |
| Campbell | 1 |
| Sacramento | 1 |
| Zapopan | 1 |
| Åkersberga | 1 |